Skip to content

Community-Driven Cervical Cancer Prevention in Western Kenya

Evaluation of a Community-Driven Cervical Cancer Prevention Strategy in Western Kenya

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02124252
Enrollment
7200
Registered
2014-04-28
Start date
2016-01-31
Completion date
2019-03-31
Last updated
2019-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma in Situ of Uterine Cervix, Human Papilloma Virus Infection

Keywords

cervical cancer screening, human papillomavirus testing, Kenya, implementation science

Brief summary

There are many challenges to implementation of cervical cancer prevention in resource-limited countries, despite evidence based screening and treatment strategies. The investigators hypothesize that self-collected HPV specimens offered in a community health campaign setting will

Interventions

BEHAVIORALCommunity-based testing with standard linkage to care

Women will be offered HPV-based cervical cancer screening followed by standard linkage to care for women who test positive (to subdistrict or district hospitals).

BEHAVIORALCommunity-based HPV testing with enhanced linkage to care

Women will be offered HPV-based cervical cancer screening followed by enhanced linkage to care using the strategies determined in partnership with the key stakeholders in the communities.

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Female, ages 25-65 Willing to sign informed consent Lives in community where randomization arm is

Exclusion criteria

* Prior hysterectomy

Design outcomes

Primary

MeasureTime frameDescription
Reach of cervical cancer screening using self-collected HPV specimens in community health campaigns compared to clinics2 yearsThe investigators will compare the number of women who uptake HPV testing in the community health campaign arms compared to the number who uptake HPV testing in the clinic-based arms.

Secondary

MeasureTime frameDescription
Determine the Efficacy of the cervical cancer prevention program4 yearsThe investigators will compare the number of women accessing treatment for positive HPV results with standard linkage to care compared to the enhanced linkage to treatment strategy.

Other

MeasureTime frameDescription
Determine the cost-effectiveness4-5 yearsThe investigators will determine the cost-effectiveness of the three strategies in this study: clinic-based testing with standard referral to care, community-health campaign testing w/ standard referral to care & community based testing w/ enhanced linkage to care.

Countries

Kenya

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026